SCM
RBOT

Saba Capital Management’s Vicarious Surgical RBOT Stock Holding History

Saba Capital Management’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-839
Closed -$256K – 455
2020
Q4 		$256K Buy
+839
New +$246K 0.01% 154

Other funds holding RBOT

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
RIA
RP Investment Advisors Toronto, Ontario, Canada $900K AUM 17.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

Saba Capital Management's RBOT Position: Q1 2021 in Review

Saba Capital Management sold out of Vicarious Surgical (RBOT) in Q1 2021, closing a stake of 839 shares — an estimated $256K sold.

Saba Capital Management first reported a position in RBOT in Q4 2020 and held it in 1 quarter. The position peaked at $256K in Q4 2020. 70 funds tracked by Wall St. Rank hold RBOT as of Q1 2021.

  • Saba Capital Management reported no remaining Vicarious Surgical position as of Q1 2021 after selling out during the quarter.
  • Saba Capital Management sold 839 Vicarious Surgical shares in Q1 2021, an estimated $256K.
  • Saba Capital Management first reported a position in Vicarious Surgical in Q4 2020 and held it in 1 quarter.
  • Saba Capital Management's Vicarious Surgical position peaked at $256K in Q4 2020.
  • 70 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2021.

Based on Saba Capital Management's 13F filing for Q1 2021, filed 17 May 2021.